Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control

<b>Background/Objectives</b>: Reference materials are essential for ensuring the accuracy and traceability of measurements in the quality control of medicinal products. This study explores new principles for the preparation of impure materials of active pharmaceutical substances, focusin...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikolay A. Shulga, Vladimir I. Gegechkori, Natalya V. Gorpinchenko, Valery V. Smirnov, Sergey P. Dementyev, Galina V. Ramenskaya
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/59
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587732061257728
author Nikolay A. Shulga
Vladimir I. Gegechkori
Natalya V. Gorpinchenko
Valery V. Smirnov
Sergey P. Dementyev
Galina V. Ramenskaya
author_facet Nikolay A. Shulga
Vladimir I. Gegechkori
Natalya V. Gorpinchenko
Valery V. Smirnov
Sergey P. Dementyev
Galina V. Ramenskaya
author_sort Nikolay A. Shulga
collection DOAJ
description <b>Background/Objectives</b>: Reference materials are essential for ensuring the accuracy and traceability of measurements in the quality control of medicinal products. This study explores new principles for the preparation of impure materials of active pharmaceutical substances, focusing on 1-(3-benzoylphenyl)ethanone ketoprofen impurity A (<i>European Pharmacopoeia</i>) as the reference material. <b>Methods</b>: The reference material was synthesised from commercially available acetanilide and benzoyl chloride. The obtained product was purified using preparative chromatography and characterised by infrared spectroscopy (IR), 1H and 13C nuclear magnetic resonance (NMR), and mass spectrometry. The structure was verified using primary research methods to confirm its identity as the target product. <b>Results</b>: The characterisation confirmed the structure and purity of 1-(3-benzoylphenyl)ethanone, achieving a purity of 99.86%, meeting regulatory documentation requirements. The synthesised product was demonstrated to be identical to the target compound and suitable for use as a reference material. <b>Conclusions</b>: The developed method provides a robust approach for the preparation and characterisation of 1-(3-benzoylphenyl)ethanone, enabling its use as a certified reference material in the quality control of medicinal products. This approach ensures compliance with regulatory standards and enhances the reliability of pharmaceutical quality assurance practices.
format Article
id doaj-art-ace2d13ef96d4e8f9133050a7eca6db6
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-ace2d13ef96d4e8f9133050a7eca6db62025-01-24T13:45:13ZengMDPI AGPharmaceuticals1424-82472025-01-011815910.3390/ph18010059Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality ControlNikolay A. Shulga0Vladimir I. Gegechkori1Natalya V. Gorpinchenko2Valery V. Smirnov3Sergey P. Dementyev4Galina V. Ramenskaya5Department of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, RussiaDepartment of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, RussiaDepartment of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, RussiaDepartment of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, RussiaDepartment of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, RussiaDepartment of Pharmaceutical and Toxicological Chemistry named after Arzamastsev, Institute of Pharmacy, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya Str., 119991 Moscow, Russia<b>Background/Objectives</b>: Reference materials are essential for ensuring the accuracy and traceability of measurements in the quality control of medicinal products. This study explores new principles for the preparation of impure materials of active pharmaceutical substances, focusing on 1-(3-benzoylphenyl)ethanone ketoprofen impurity A (<i>European Pharmacopoeia</i>) as the reference material. <b>Methods</b>: The reference material was synthesised from commercially available acetanilide and benzoyl chloride. The obtained product was purified using preparative chromatography and characterised by infrared spectroscopy (IR), 1H and 13C nuclear magnetic resonance (NMR), and mass spectrometry. The structure was verified using primary research methods to confirm its identity as the target product. <b>Results</b>: The characterisation confirmed the structure and purity of 1-(3-benzoylphenyl)ethanone, achieving a purity of 99.86%, meeting regulatory documentation requirements. The synthesised product was demonstrated to be identical to the target compound and suitable for use as a reference material. <b>Conclusions</b>: The developed method provides a robust approach for the preparation and characterisation of 1-(3-benzoylphenyl)ethanone, enabling its use as a certified reference material in the quality control of medicinal products. This approach ensures compliance with regulatory standards and enhances the reliability of pharmaceutical quality assurance practices.https://www.mdpi.com/1424-8247/18/1/59related substancesketoprofen impurityreference materialpurification
spellingShingle Nikolay A. Shulga
Vladimir I. Gegechkori
Natalya V. Gorpinchenko
Valery V. Smirnov
Sergey P. Dementyev
Galina V. Ramenskaya
Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
Pharmaceuticals
related substances
ketoprofen impurity
reference material
purification
title Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
title_full Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
title_fullStr Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
title_full_unstemmed Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
title_short Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
title_sort development of ketoprofen impurity a 1 3 benzoylphenyl ethanone as a certified reference material for pharmaceutical quality control
topic related substances
ketoprofen impurity
reference material
purification
url https://www.mdpi.com/1424-8247/18/1/59
work_keys_str_mv AT nikolayashulga developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol
AT vladimirigegechkori developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol
AT natalyavgorpinchenko developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol
AT valeryvsmirnov developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol
AT sergeypdementyev developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol
AT galinavramenskaya developmentofketoprofenimpuritya13benzoylphenylethanoneasacertifiedreferencematerialforpharmaceuticalqualitycontrol